United States · 
Who invested in Boreal Genomics?
Boreal Genomics's investors include ARCH Venture Partners, In-Q-Tel and Kearny Venture Partners.
201120122013
$6.5MSeries A$18MSeries C
United States · Series C startup
Who invested in Boreal Genomics
2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Boreal Genomics and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$24Mraised across 2 rounds since 2010, from 2 sources
$6.5MSeries A$18MSeries C
- Latest round
- Series C, $18MOct 2013
- Step-upi
- 2.8×
- Investors
- 3
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $6.5M Oct 2010
- Biggest round
- $18M Series C · Oct 2013
- Between rounds
- 3 years from the last two
The rounds
- Oct 2013Series C$18M2 new
Reported by finsmes.comSEC filing: $18M sold, first sale Sept 2013
- Oct 2010
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Boreal Genomics
How much has Boreal Genomics raised?
Boreal Genomics has raised $24M across 2 rounds since 2010.
When did Boreal Genomics last raise?
Boreal Genomics's most recent round was a Series C of $18M in Oct 2013.
What was Boreal Genomics's biggest round?
Its most recent round, $18M in Oct 2013, is also its largest on record.
Who backed Boreal Genomics first?
Boreal Genomics's first round on record, in Oct 2010, was backed by In-Q-Tel.
What stage is Boreal Genomics at?
Boreal Genomics's latest named round is a Series C, in Oct 2013.
Where is Boreal Genomics based?
Boreal Genomics is based in the United States.
Companies like Boreal Genomics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.